Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.23 Down 0.00(0.88%) Mar 27, 4:01PM EDT
Add to Portfolio
Prev Close:0.23
Open:0.23
Bid:0.22 x 100
Ask:0.25 x 900
1y Target Est:3.00
Beta:0.32
Next Earnings Date:N/A
Day's Range:0.23 - 0.23
52wk Range:0.21 - 0.42
Volume:919,612
Avg Vol (3m):1,906,200
Market Cap:45.01M
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
HEBDown 0.88%45.01M
GILDDown 0.07%150.43B
MRKUp 0.26%163.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):235.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback